PMGC (NASDAQ:ELAB) Releases Quarterly Earnings Results

PMGC (NASDAQ:ELAB) released its earnings results on Friday. The company reported ($0.61) earnings per share (EPS) for the quarter, FiscalAI reports. The company had revenue of $1.31 million for the quarter.

PMGC Trading Up 1.5%

Shares of NASDAQ ELAB traded up $0.01 during midday trading on Friday, hitting $0.91. The stock had a trading volume of 596,807 shares, compared to its average volume of 530,601. The company has a market capitalization of $1.06 million, a price-to-earnings ratio of -0.01 and a beta of -0.25. PMGC has a 1-year low of $0.84 and a 1-year high of $309.12. The company has a quick ratio of 1.43, a current ratio of 1.45 and a debt-to-equity ratio of 0.03. The company has a fifty day moving average price of $1.14 and a 200 day moving average price of $4.04.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PMGC in a research note on Friday, June 26th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, PMGC currently has an average rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.